Stevanato Group (NYSE:STVN) Releases FY24 Earnings Guidance

Stevanato Group (NYSE:STVN) updated its FY24 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of €0.47-0.49 for the period, compared to the consensus estimate of $0.48. The company issued revenue guidance of €1.09-1.11 billion, compared to the consensus revenue estimate of $1.09 billion. Stevanato Group also updated its FY 2024 guidance to 0.517-0.539 EPS.

Stevanato Group Stock Performance

Shares of Stevanato Group stock traded up €0.17 ($0.19) on Thursday, hitting €22.72 ($24.97). The stock had a trading volume of 383,800 shares, compared to its average volume of 510,737. The stock’s 50-day simple moving average is €19.66 and its two-hundred day simple moving average is €20.31. Stevanato Group has a one year low of €16.56 ($18.20) and a one year high of €34.73 ($38.16). The company has a quick ratio of 1.13, a current ratio of 1.74 and a debt-to-equity ratio of 0.19.

Stevanato Group (NYSE:STVN) last released its quarterly earnings data on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The firm had revenue of €277.90 million during the quarter, compared to analysts’ expectations of €274.36 million. Stevanato Group had a net margin of 11.27% and a return on equity of 10.89%. Stevanato Group’s revenue was up 2.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.16 EPS. As a group, equities analysts predict that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Citigroup cut their price objective on Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Morgan Stanley reduced their price objective on shares of Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Monday, July 15th.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.